Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Collection of blood and brain tissue samples from patients with drug-resistant epilepsy

Official title: Multimodal Study of the Human Brain Epilepsy Tissue

Run by Assistance Publique - Hôpitaux de Paris · NCT06022055 · Data updated 2026-11-12

This study is collecting blood and brain tissue samples from adults with drug-resistant epilepsy who are having surgery to help researchers find new ways to understand and treat the condition.

More Drug Resistant Epilepsy trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedFebruary 29, 2024
Main results expectedFebruary 28, 2037
Study endsFebruary 28, 2037
Registry record updatedJuly 16, 2026
Trial IDNCT06022055 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with focal drug-resistant epilepsy who are hospitalized for pre-surgical evaluation or surgery.

Probably not a fit

Patients who do not have focal drug-resistant epilepsy or are under 18 years old may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on collecting blood and brain tissue samples from adult patients with focal drug-resistant epilepsy who are undergoing surgery. The goal is to create an annotated biorepository to support research aimed at identifying new pathophysiological biomarkers associated with the condition. Investigators will employ a multimodal approach, including electrophysiological analyses, immunohistochemistry, genetic studies, and biochemical analyses. Samples will be stored for future research, and patients will be followed up for clinical evaluations within 36 months post-surgery.

Why it matters

Potential benefit: If successful, this study could lead to the identification of new biomarkers that improve the understanding and treatment of drug-resistant epilepsy.

How similar studies have gone: While similar studies have explored biomarkers in epilepsy, this multimodal approach to creating a biorepository is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 yo or above
* patients with a focal drug-resistant epilepsy
* patients hospitalized for a pre-surgical evaluation or for an epilepsy surgery
* consent obtained from the patient, or legally authorized representative
* affiliated to a social security system

Exclusion Criteria:

* None

Where it's running

  • Department of Neurology, Epilepsy Unit, Pitié-Salpêtrière Hospital
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.